New Zealand markets closed

Nutex Health Inc. (NUTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.6825+0.0155 (+2.32%)
At close: 04:00PM EDT
0.6750 -0.01 (-1.10%)
After hours: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 33.16M
Enterprise value 275.55M
Trailing P/E 1.11
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.11
Price/book (mrq)0.53
Enterprise value/revenue 1.06
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.44
52-week change 3-90.16%
S&P500 52-week change 322.26%
52-week high 38.2500
52-week low 30.5000
50-day moving average 30.8872
200-day moving average 32.4003

Share statistics

Avg vol (3-month) 3291k
Avg vol (10-day) 3134.09k
Shares outstanding 549.72M
Implied shares outstanding 651.43M
Float 828.01M
% held by insiders 142.66%
% held by institutions 19.95%
Shares short (15 May 2024) 4325.39k
Short ratio (15 May 2024) 40.82
Short % of float (15 May 2024) 41.06%
Short % of shares outstanding (15 May 2024) 40.65%
Shares short (prior month 15 Apr 2024) 4178.8k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 301 Nov 2019
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 310 Apr 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -15.85%
Operating margin (ttm)2.15%

Management effectiveness

Return on assets (ttm)0.66%
Return on equity (ttm)-39.09%

Income statement

Revenue (ttm)258.77M
Revenue per share (ttm)5.70
Quarterly revenue growth (yoy)19.70%
Gross profit (ttm)N/A
EBITDA 12.38M
Net income avi to common (ttm)-41M
Diluted EPS (ttm)0.6000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)30.01M
Total cash per share (mrq)0.6
Total debt (mrq)272.39M
Total debt/equity (mrq)340.44%
Current ratio (mrq)1.68
Book value per share (mrq)1.27

Cash flow statement

Operating cash flow (ttm)3.26M
Levered free cash flow (ttm)3.96M